Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

360 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder.
Brunner D, Kabitzke P, He D, Cox K, Thiede L, Hanania T, Sabath E, Alexandrov V, Saxe M, Peles E, Mills A, Spooren W, Ghosh A, Feliciano P, Benedetti M, Luo Clayton A, Biemans B. Brunner D, et al. PLoS One. 2015 Aug 14;10(8):e0134572. doi: 10.1371/journal.pone.0134572. eCollection 2015. PLoS One. 2015. PMID: 26273832 Free PMC article.
Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HD.
Curtin PC, Farrar AM, Oakeshott S, Sutphen J, Berger J, Mazzella M, Cox K, He D, Alosio W, Park LC, Howland D, Brunner D. Curtin PC, et al. Front Behav Neurosci. 2016 Jan 11;9:361. doi: 10.3389/fnbeh.2015.00361. eCollection 2015. Front Behav Neurosci. 2016. PMID: 26793080 Free PMC article.
Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline.
Menalled LB, Patry M, Ragland N, Lowden PA, Goodman J, Minnich J, Zahasky B, Park L, Leeds J, Howland D, Signer E, Tobin AJ, Brunner D. Menalled LB, et al. PLoS One. 2010 Mar 22;5(3):e9793. doi: 10.1371/journal.pone.0009793. PLoS One. 2010. PMID: 20339553 Free PMC article.
Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.
El-Khodor BF, Edgar N, Chen A, Winberg ML, Joyce C, Brunner D, Suárez-Fariñas M, Heyes MP. El-Khodor BF, et al. Exp Neurol. 2008 Jul;212(1):29-43. doi: 10.1016/j.expneurol.2008.02.025. Epub 2008 Mar 18. Exp Neurol. 2008. PMID: 18455159
., Coovert, D.D., Gavrilina, T.O., Xing, L., Bassell, G.J., and Burghes, A.H. 2005. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. ...
., Coovert, D.D., Gavrilina, T.O., Xing, L., Bassell, G.J., and Burghes, A.H. 2005. SMNDelta7, the major product of the centro …
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.
Menalled L, El-Khodor BF, Patry M, Suárez-Fariñas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V, Yang XW, MacDonald M, Morton AJ, Bates G, Leeds J, Park L, Howland D, Signer E, Tobin A, Brunner D. Menalled L, et al. Neurobiol Dis. 2009 Sep;35(3):319-36. doi: 10.1016/j.nbd.2009.05.007. Epub 2009 May 21. Neurobiol Dis. 2009. PMID: 19464370 Free PMC article.
Human glia can both induce and rescue aspects of disease phenotype in Huntington disease.
Benraiss A, Wang S, Herrlinger S, Li X, Chandler-Militello D, Mauceri J, Burm HB, Toner M, Osipovitch M, Jim Xu Q, Ding F, Wang F, Kang N, Kang J, Curtin PC, Brunner D, Windrem MS, Munoz-Sanjuan I, Nedergaard M, Goldman SA. Benraiss A, et al. Nat Commun. 2016 Jun 7;7:11758. doi: 10.1038/ncomms11758. Nat Commun. 2016. PMID: 27273432 Free PMC article.
Pharmacological manipulations of interval timing using the peak procedure in male C3H mice.
Balci F, Ludvig EA, Gibson JM, Allen BD, Frank KM, Kapustinski BJ, Fedolak TE, Brunner D. Balci F, et al. Psychopharmacology (Berl). 2008 Nov;201(1):67-80. doi: 10.1007/s00213-008-1248-y. Epub 2008 Jul 23. Psychopharmacology (Berl). 2008. PMID: 18648777
MATERIALS AND METHODS: C3H mice were tested in the peak procedure, a timing task, following acute administration of two putative cognitive enhancers (atomoxetine and physostigmine), two cognitive disruptors (scopolamine and chlordiazepoxide [CDP]), or two dopamine agonists (D
MATERIALS AND METHODS: C3H mice were tested in the peak procedure, a timing task, following acute administration of two putative cognitive e …
Age-related sperm DNA methylation changes are transmitted to offspring and associated with abnormal behavior and dysregulated gene expression.
Milekic MH, Xin Y, O'Donnell A, Kumar KK, Bradley-Moore M, Malaspina D, Moore H, Brunner D, Ge Y, Edwards J, Paul S, Haghighi FG, Gingrich JA. Milekic MH, et al. Mol Psychiatry. 2015 Aug;20(8):995-1001. doi: 10.1038/mp.2014.84. Epub 2014 Aug 5. Mol Psychiatry. 2015. PMID: 25092244
The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?
Olivier B, Leahy C, Mullen T, Paylor R, Groppi VE, Sarnyai Z, Brunner D. Olivier B, et al. Psychopharmacology (Berl). 2001 Jul;156(2-3):284-90. doi: 10.1007/s002130100828. Psychopharmacology (Berl). 2001. PMID: 11549230
360 results
Jump to page
Feedback